The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer
Keliang Wang(Harbin Medical University), Chawnshang Chang(University of Rochester Medical Center)
Cited by 92
Related Papers
LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling
|Nature Communications|2019|223
Abnormal Mammary Gland Development and Growth Retardation in Female Mice and MCF7 Breast Cancer Cells Lacking Androgen Receptor
|The Journal of Experimental Medicine|2003|148
Metformin Inhibits Nuclear Receptor TR4–Mediated Hepatic Stearoyl-CoA Desaturase 1 Gene Expression With Altered Insulin Sensitivity
|Diabetes|2011|97
Tissue Prostate-Specific Antigen Facilitates Refractory Prostate Tumor Progression via Enhancing ARA70-Regulated Androgen Receptor Transactivation
|Cancer Research|2008|87
Induction of the Intronic Enhancer of the Human Ciliary Neurotrophic Factor Receptor (CNTFRä) Gene by the TR4 Orphan Receptor
|Journal of Biological Chemistry|1997|60